KR940003550A - 노인성 치매 예방 및 치료방법 - Google Patents
노인성 치매 예방 및 치료방법 Download PDFInfo
- Publication number
- KR940003550A KR940003550A KR1019930015610A KR930015610A KR940003550A KR 940003550 A KR940003550 A KR 940003550A KR 1019930015610 A KR1019930015610 A KR 1019930015610A KR 930015610 A KR930015610 A KR 930015610A KR 940003550 A KR940003550 A KR 940003550A
- Authority
- KR
- South Korea
- Prior art keywords
- senile dementia
- prevent
- calpine
- dementia
- treat senile
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
칼파인 억제제를 필수 성분으로 함유하는 노인성 치매 치료제 또는 예방제를 제공한다.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 노인성 치매 또는 헌팅톤 질환 환자와정상인 (대조)에 있어서 칼파인 I의 나타내는 그래프.
Claims (4)
- 필수성분으로서 칼파인 억제제를 함유하는 노인
- 필수 성분으로서 칼파인 억제제를 항유하고 이와 치매 치료 또는 예방을 위한 약제학적 조성물.
- 노인성 치때 환자 또는 노인성 치매의 우려가 있는 더불어 약제학적으로 허용되는 담체를 함유하는 노인성 치료방법.
- 노인성 치매의 치료 또는 예방을 위한 칼파인 억제제의 용도.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93064792A | 1992-08-14 | 1992-08-14 | |
US7/930,647 | 1992-08-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR940003550A true KR940003550A (ko) | 1994-03-12 |
Family
ID=25459574
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019930015610A KR940003550A (ko) | 1992-08-14 | 1993-08-12 | 노인성 치매 예방 및 치료방법 |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPH06172211A (ko) |
KR (1) | KR940003550A (ko) |
CA (1) | CA2101417A1 (ko) |
TW (1) | TW268896B (ko) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69815137T2 (de) * | 1997-09-04 | 2004-04-08 | Nippon Chemiphar Co. Ltd. | Epoxybernsteinsäureamid-derivate |
-
1993
- 1993-07-27 CA CA002101417A patent/CA2101417A1/en not_active Abandoned
- 1993-08-12 KR KR1019930015610A patent/KR940003550A/ko not_active Application Discontinuation
- 1993-08-13 JP JP5201519A patent/JPH06172211A/ja active Pending
- 1993-08-23 TW TW082106789A patent/TW268896B/zh active
Also Published As
Publication number | Publication date |
---|---|
JPH06172211A (ja) | 1994-06-21 |
CA2101417A1 (en) | 1994-02-15 |
TW268896B (ko) | 1996-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1649853A3 (en) | Microtubule stabilizing agents for treating atherosclerosis or restenosis | |
BR0012136A (pt) | Inibidores de reabsorção de norepinefrina altamente seletivos e métodos de uso dos mesmos | |
IE893840L (en) | Use of acetyl d-carnitines for treating glaucoma | |
KR930702000A (ko) | 노년기 치매, 식용항진, 편두통, 또는 식용불량의 치료를 위한 파로세틴의 사용 | |
ATE146677T1 (de) | Pharmazeutische formulierung zur behandlung der nicotinabhängigkeit | |
KR910004187A (ko) | 세트랄린을 사용한 조기사정의 치료방법 | |
PT914110E (pt) | Metodo de modulacao da micro-circulacao | |
FI930038A0 (fi) | Minskande eller foerhindrande av hudirritation med laekemedel | |
UA35567C2 (uk) | Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату | |
HUP0001063A2 (hu) | Zöld porfirinek alkalmazása ateroszklerózis kezelésére szolgáló gyógyászati készítmények előállítására | |
KR970061244A (ko) | 치매 치료용 약학 조성물 | |
DE3778008D1 (de) | Ketonderivate als arzneimittel zur behandlung oder vorbeugung des entzugssyndromes. | |
CA2156481A1 (en) | 5-ht2 receptor antagonist compositions useful in treating venous conditions | |
KR950016760A (ko) | 치질 치료제 | |
ES2196167T3 (es) | Composicion farmaceutica que contiene propionato de 3-(2,2,2-trimetilhidrazinio) y gamma-butirobetaina para el tratamiento de enfermedades cardiovasculares. | |
ES2096207T3 (es) | Prevencion y tratamiento de aterosclerosis. | |
KR960703593A (ko) | (R)-암로디핀에 의한 평활근 세포 이동의 억제 (Inhibition of Smooth Muscle Cell Migration by (R)-Amlodipine) | |
KR940003550A (ko) | 노인성 치매 예방 및 치료방법 | |
ES2104223T3 (es) | 2-((2-(n-isobutil-n-metil)amino)-bencilsulfinil)bencimidazol como agente antimicrobiano contra helicobacter pylori. | |
DE69424679T2 (de) | Zusammensetzung zur behandlung oder vorbeugung von herpes | |
WO1997026880A3 (en) | Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients | |
MX9700036A (es) | Combinacion de compuestos, uso en la preparacion de composiciones para tratar infeccion por el vir s de inmunodeficiencia humana, y composiciones obtenidas. | |
RU96115138A (ru) | Применение диметикона для лечения запоров | |
KR960003741A (ko) | 조골세포 증식인자 | |
ATE316373T1 (de) | Conagenin zur behandlung von ulzerativer kolitis und/oder morbus crohn |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Withdrawal due to no request for examination |